$59.00 10 in stock Specifications Content: 5mg per vial Form: Lyophilized powder Purity: 98% (lab tested) Application: Laboratory research only Product Rating 0.0 (0 reviews)
The reduced dose, not the reduced frequency, is what defines microdosing
In the DPP-4/Diprotin A co-crystal structure (PDB ID 1nu8), the peptide bond between the second and third residues is not cleaved after formation of the tetrahedral intermediate, wherein the sidechain of the catalytic serine (Ser630) is covalently linked to the carbonyl carbon atom Pro2
Mandatory Research Disclaimer Alluvi products are strictly for in-vitro laboratory research purposes only
Orthopaedic Sports Medicine Systematic Review (PMC, 2024) A systematic review of BPC-157 in orthopaedic sports medicine conducted via searches of PubMed, Cochrane, and Embase from inception to June 2024 confirmed pre-clinical evidence across fractures, tendon ruptures, ligament tears, and muscle injuries, documenting BPC-157s ability to modulate growth factor expression and enhance fibroblast migration to injury sites across all studied tissue types
The most common adverse effects include gastrointestinal symptoms (diarrhea in up to 30% of patients and nausea in 22%) and mild aminotransferase elevations (typically transient and asymptomatic)
